title: TAVI with current CE-marked devices: strategies for optimal sizing and valve delivery.
abstract: Transcatheter aortic valve implantation (TAVI) has evolved from an exclusive, highly complex and hazardous procedure into a mature, safe and streamlined therapy for patients with severe aortic stenosis (AS). Various successive device iterations and product refinements have created a dynamic and competitive field with a spectrum of different CE-marked transcatheter heart valve (THV) designs. This review provides a practical overview of current CE-marked THVs with a focus on respective sizing algorithms and delivery strategies.
authors.affiliation: Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands.
authors.forename: Lennart
authors.initials: L
authors.lastname: van Gils
authors.forename: Didier
authors.initials: D
authors.lastname: Tchetche
authors.forename: Azeem
authors.initials: A
authors.lastname: Latib
authors.forename: Carmelo
authors.initials: C
authors.lastname: Sgroi
authors.forename: Ganesh
authors.initials: G
authors.lastname: Manoharan
authors.forename: Helge
authors.initials: H
authors.lastname: Möllmann
authors.forename: Nicolas M
authors.initials: NM
authors.lastname: Van Mieghem
mesh_terms: D000465:Algorithms; D001021:Aortic Valve / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000601:surgery*; D001024:Aortic Valve Stenosis / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000601:surgery*; D001027:Aortography / Q000379:methods; D000072226:Computed Tomography Angiography; D003661:Decision Support Techniques; D004452:Echocardiography; D005471:Fluoroscopy; D006350:Heart Valve Prosthesis; D006801:Humans; D008279:Magnetic Resonance Imaging; D061330:Multidetector Computed Tomography; D018579:Patient Selection; D011237:Predictive Value of Tests; D011474:Prosthesis Design; D015641:Radiography, Interventional / Q000379:methods; D012307:Risk Factors; D012720:Severity of Illness Index; D065467:Transcatheter Aortic Valve Replacement / Q000009:adverse effects / Q000295:instrumentation* / Q000379:methods; D016896:Treatment Outcome